- A Case of Successful Living Donor Liver Transplantation after Downstaging of Hepatocellular Carcinoma with the Beyond Milan Criteria by Radioembolization, Hepatic Arterial Infusion Chemotherapy, and Stereotactic Body Radiation Therapy
-
Yeong Jin Kim, Yeon Seung Chung, Beom Kyung Kim, Jin Sil Sung, Do Young Kim
-
J Liver Cancer. 2017;17(2):182-185. Published online September 30, 2017
-
DOI: https://doi.org/10.17998/jlc.17.2.182
-
-
Abstract
PDF
- Liver transplantation for patients with hepatocellular carcinoma (HCC) within the Milan criteria
generally yields a 4-year overall survival rate of 75% and 4-year recurrence free survival rate of 83%.
But, many HCC patients present with the disease beyond the Milan criteria. On the other hands, the
overall survival of patients with advanced HCC with portal vein invasion is very poor. We report a
case of successful living donor liver transplantation for advanced HCC with portal vein invasion by
down-staging through radioembolization, hepatic arterial infusion chemotherapy, and stereotactic
body radiation therapy.
- A Case of Complete Remission in Patient with Extrahepatic Metastasis after Curative Resection of Hepatocellular Carcinoma by Radiotherapy, Lung Resection and Systemic Chemotherapy
-
Yeong Jin Kim, Hye won Lee, Ji Hoon Lee, Jin Sil Sung, Do Young Kim
-
J Liver Cancer. 2016;16(1):63-66. Published online March 31, 2016
-
DOI: https://doi.org/10.17998/jlc.16.1.63
-
-
Abstract
PDF
- Surgical resection is mainstay treatment of hepatocellular carcinoma (HCC). However, its
prognosis is poor, because of the high incidence of HCC recurrence (cumulative 5-year HCC
recurrence rate of 70-80%). The most common site of HCC recurrence is the remnant liver, and
extrahepatic recurrence occurs in 6.7-13.5% of patients. Because the tumor characteristics in
extrahepatic recurrence are usually multiple and aggressive, the optimal treatment modality
has not yet been determined. We report a case of complete remission and long term survival
over 60 months in patient with extrahepatic metastasis after curative resection of HCC
by aggressive treatment, which include lung resection for lung metastasis, radiotherapy
for mediastinal lymph node metastasis, and systemic chemotherapy.
|